Literature DB >> 16546860

Changes from 1992 to 2002 in the pretreatment delay for patients with squamous cell carcinoma of larynx or pharynx: a Danish nationwide survey from DAHANCA.

Hanne Primdahl1, Anni Linnet Nielsen, Susanne Larsen, Elo Andersen, Merete Ipsen, Christel Lajer, Lene Weber Vestermark, Lisbeth J Andersen, Hanne Sand Hansen, Marie Overgaard, Jens Overgaard, Cai Grau.   

Abstract

In Denmark, a general impression of prolonged pretreatment delay for patients with head and neck cancer led to a nationwide study of time spans from symptom debut over first health care contact to start of treatment. Charts of consecutive new patients with squamous cell carcinoma of the pharynx and larynx, seen at the five Danish oncology centers in January-April 1992 and 2002, respectively, were reviewed. Of the 288 patients identified, definitive treatment was radiotherapy in 264 cases, surgery in one case. Twenty-three patients had neither surgery nor radiotherapy. Total time from first health care contact to start of definitive treatment was significantly longer in 2002 than in 1992 (median 70 versus 50 days, p<0.001). There was no significantly difference in time used for diagnosis. Time for treatment preparation and planning was 46 days in 2002 versus 31 days in 1992 (p<0.001). Significantly more diagnostic procedures (CT, MR, US, PET) were done in 2002. In conclusion, this nationwide study showed that waiting time before start of radiotherapy was significantly longer in 2002 compared to 1992. An increasing number of imaging procedures including CT-based dose planning was observed. The prolongation was mainly related to shortage of radiotherapy capacity. The three weeks extra pretreatment delay could theoretically lead to a 10% lower tumor control probability in 2002 compared to 1992.

Entities:  

Mesh:

Year:  2006        PMID: 16546860     DOI: 10.1080/02841860500423948

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  8 in total

1.  Having Medicaid insurance negatively impacts outcomes in patients with head and neck malignancies.

Authors:  Arash O Naghavi; Michelle I Echevarria; G Daniel Grass; Tobin J Strom; Yazan A Abuodeh; Kamran A Ahmed; Youngchul Kim; Andy M Trotti; Louis B Harrison; Kosj Yamoah; Jimmy J Caudell
Journal:  Cancer       Date:  2016-08-01       Impact factor: 6.860

2.  Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States.

Authors:  Colin T Murphy; Thomas J Galloway; Elizabeth A Handorf; Brian L Egleston; Lora S Wang; Ranee Mehra; Douglas B Flieder; John A Ridge
Journal:  J Clin Oncol       Date:  2015-11-30       Impact factor: 44.544

3.  A "package solution" fast track program can reduce the diagnostic waiting time in head and neck cancer.

Authors:  Jesper Roed Sorensen; Jørgen Johansen; Lars Gano; Jens Ahm Sørensen; Stine Rosenkilde Larsen; Peter Bøgeskov Andersen; Anders Thomassen; Christian Godballe
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-06-18       Impact factor: 2.503

4.  Assessment of performance indicators of a radiotherapy department using an electronic medical record system.

Authors:  Yasir A Bahadur; Camelia Constantinescu; Ammar Y Bahadur; Ruba Y Bahadur
Journal:  Rep Pract Oncol Radiother       Date:  2017-07-21

5.  Impact of waiting time on nodal staging in head and neck squamous-cell carcinoma treated with radical intensity modulated radiotherapy.

Authors:  Cédric Chevalier; Aurélie Bertaut; Magali Quivrin; Noémie Vulquin; Cédric Desandes; Mireille Folia; Christian Duvillard; Gilles Truc; Gilles Crehange; Philippe Maingon
Journal:  Clin Transl Radiat Oncol       Date:  2016-12-21

6.  Prognostic value of the interval from surgery to initiation of radiation therapy in correlation with some histo-clinical parameters in patients with malignant supratentorial gliomas.

Authors:  Bogdan Gliński; Jacek Urbański; Marcin Hetnał; Krzysztof Małecki; Magdalena Jarosz; Anna Mucha-Małecka; Agnieszka Chrostowska; Ewa Jakubowicz; Beata Frączek-Błachut; Paweł Dymek
Journal:  Contemp Oncol (Pozn)       Date:  2012-02-29

7.  Implementation of a rapid learning platform: Predicting 2-year survival in laryngeal carcinoma patients in a clinical setting.

Authors:  Tim Lustberg; Michael Bailey; David I Thwaites; Alexis Miller; Martin Carolan; Lois Holloway; Emmanuel Rios Velazquez; Frank Hoebers; Andre Dekker
Journal:  Oncotarget       Date:  2016-06-14

8.  Diagnostic and therapeutic delay in patients with larynx cancer at a reference public hospital.

Authors:  Ali Amar; Helma Maria Chedid; Sergio Altino Franzi; Abrão Rapoport
Journal:  Braz J Otorhinolaryngol       Date:  2010 Nov-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.